Literature DB >> 24945127

Topical and peripheral ketamine as an analgesic.

Jana Sawynok1.   

Abstract

Ketamine, in subanesthetic doses, produces systemic analgesia in chronic pain settings, an action largely attributed to block of N-methyl-D-aspartate receptors in the spinal cord and inhibition of central sensitization processes. N-methyl-D-aspartate receptors also are located peripherally on sensory afferent nerve endings, and this provided the initial impetus for exploring peripheral applications of ketamine. Ketamine also produces several other pharmacological actions (block of ion channels and receptors, modulation of transporters, anti-inflammatory effects), and while these may require higher concentrations, after topical (e.g., as gels, creams) and peripheral application (e.g., localized injections), local tissue concentrations are higher than those after systemic administration and can engage lower affinity mechanisms. Peripheral administration of ketamine by localized injection produced some alterations in sensory thresholds in experimental trials in volunteers and in complex regional pain syndrome subjects in experimental settings, but many variables were unaltered. There are several case reports of analgesia after topical application of ketamine given alone in neuropathic pain, but controlled trials have not confirmed such effects. A combination of topical ketamine with several other agents produced pain relief in case, and case series, reports with response rates of 40% to 75% in retrospective analyses. In controlled trials of neuropathic pain with topical ketamine combinations, there were improvements in some outcomes, but optimal dosing and drug combinations were not clear. Given orally (as a gargle, throat swab, localized peritonsillar injections), ketamine produced significant oral/throat analgesia in controlled trials in postoperative settings. Topical analgesics are likely more effective in particular conditions (patient factors, disease factors), and future trials of topical ketamine should include a consideration of factors that could predispose to favorable outcomes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24945127     DOI: 10.1213/ANE.0000000000000246

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  13 in total

1.  Comparison of topical ropivacaine with and without ketamine on post-surgical pain in children undergoing tonsillectomy: a randomized controlled double-blind study.

Authors:  Boohwi Hong; Chae Seong Lim; Yoon-Hee Kim; Jung Un Lee; Yong Min Kim; Choonho Jung; Yumin Jo
Journal:  J Anesth       Date:  2017-04-13       Impact factor: 2.078

2.  Effects of the noncompetitive N-methyl-d-aspartate receptor antagonists ketamine and MK-801 on pain-stimulated and pain-depressed behaviour in rats.

Authors:  T M Hillhouse; S S Negus
Journal:  Eur J Pain       Date:  2016-02-23       Impact factor: 3.931

3.  Chemogenomics knowledgebase and systems pharmacology for hallucinogen target identification-Salvinorin A as a case study.

Authors:  Xiaomeng Xu; Shifan Ma; Zhiwei Feng; Guanxing Hu; Lirong Wang; Xiang-Qun Xie
Journal:  J Mol Graph Model       Date:  2016-08-08       Impact factor: 2.518

4.  Treatment of Neuropathic Pain.

Authors:  Matthew T Mendlik; Tanya J Uritsky
Journal:  Curr Treat Options Neurol       Date:  2015-12       Impact factor: 3.598

5.  An Ethical Exploration of Barriers to Research on Controlled Drugs.

Authors:  Michael H Andreae; Evelyn Rhodes; Tyler Bourgoise; George M Carter; Robert S White; Debbie Indyk; Henry Sacks; Rosamond Rhodes
Journal:  Am J Bioeth       Date:  2016       Impact factor: 11.229

Review 6.  Ketamine as an adjuvant to opioids for cancer pain.

Authors:  Rae F Bell; Christopher Eccleston; Eija A Kalso
Journal:  Cochrane Database Syst Rev       Date:  2017-06-28

Review 7.  Topical analgesics for neuropathic pain in the elderly: current and future prospects.

Authors:  Jana Sawynok
Journal:  Drugs Aging       Date:  2014-12       Impact factor: 3.923

8.  Differential Efficacy of Ketamine in the Acute versus Chronic Stages of Complex Regional Pain Syndrome in Mice.

Authors:  Maral Tajerian; David Leu; Phillip Yang; Ting Ting Huang; Wade S Kingery; J David Clark
Journal:  Anesthesiology       Date:  2015-12       Impact factor: 7.892

9.  Topical and intranasal analgesic therapy in a woman with refractory postherpetic neuralgia.

Authors:  Kenneth C Hohmeier; Lyndsey M Almon
Journal:  Case Rep Med       Date:  2015-04-09

10.  Acute effect of topical menthol on chronic pain in slaughterhouse workers with carpal tunnel syndrome: triple-blind, randomized placebo-controlled trial.

Authors:  Emil Sundstrup; Markus D Jakobsen; Mikkel Brandt; Kenneth Jay; Juan Carlos Colado; Yuling Wang; Lars L Andersen
Journal:  Rehabil Res Pract       Date:  2014-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.